Santa Cruz Biotechnology features a diverse variety of HSV-1 gE monoclonal antibodies for research focused on understanding glycoprotein E in herpes simplex virus type 1. HSV-1 gE Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glycoprotein E is crucial for the viral entry and spread of HSV-1, playing a significant role in the virus's ability to evade the host immune response. Understanding HSV-1 gE function is essential for developing therapeutic strategies and vaccines against herpes simplex virus infections. Research on HSV-1 gE can provide insights into viral pathogenesis and the mechanisms of viral latency. HSV-1 gE monoclonal antibodies enable precise detection and characterization of viral proteins during infection and immune response studies. Investigating HSV-1 gE expression patterns helps reveal the dynamics of viral infection and host-pathogen interactions. Santa Cruz Biotechnology monoclonal antibodies for HSV-1 gE support researchers worldwide in advancing our understanding of herpes simplex virus biology and developing new therapeutic approaches.